http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#head http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#provenance http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://rdf.disgenet.org/resource/gda/DGN83dd538cc70db8abfa99825b4d3d4245 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/142 http://rdf.disgenet.org/resource/gda/DGN83dd538cc70db8abfa99825b4d3d4245 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C1140680 http://rdf.disgenet.org/resource/gda/DGN83dd538cc70db8abfa99825b4d3d4245 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#provenance http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://purl.org/dc/terms/description [We assess key issues in anti-angiogenic treatment including potential ways for addressing resistance; we review the current studies of PARP inhibitor treatment, which shows most promise in patients with germline BRCA mutations; we describe the potential for folate-receptor-directed therapy, given the high level of FR expression in ovarian cancer and we highlight the potential for molecular targeted therapy, focusing on specific subgroups of the disease with targets such as the PI3 K/AKT and RAS/RAF/MEK pathways and the ErbB family of oncogenes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/24265409 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/dc/terms/created 2017-10-17T13:10:17+02:00 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP17184.RA52nYe_5RMJyNisIMXT-_v-wOG-jKaXOi7cMoigmp2zc http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0